Sanofi pulls obesity drug application in U.S.

(Reuters) - The French drugmaker said it would work towards resubmitting the medicine, known by the brand names Acomplia and Zimulti, at a future date and would undertake necessary talks with the Food and Drug Administration on required modifications to its file.




Read more at Reuters.com Government Filings News